Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Number of items: 6.

Journal Article

Golfmann, K., Meder, L., Schuldt, P. and Ullrich, R. (2016). The role of FGFR1 signaling in breast cancer to induce tumor angiogenesis. Oncol. Res. Treat., 39. S. 118 - 119. BASEL: KARGER. ISSN 2296-5262

Meder, L., Koenig, K., Dietlein, F., Florin, A., Koker, M., Buettner, R., Heukamp, L. and Ullrich, R. (2018). LIN28B enhanced tumorigenesis in an autochthonous KRASG12V driven lung carcinoma mouse model. Oncol. Res. Treat., 41. S. 291 - 292. BASEL: KARGER. ISSN 2296-5262

Meder, L., Schuldt, P., Vlasic, I, Volz, C., Golfmann, K., Zaplatina, A., Florin, A., Tharun, L., Buettner, R., Reinhardt, C. and Ullrich, R. (2016). Combining anti-VEGF therapy and immune checkpoint inhibitors improves outcome in small cell lung carcinomas. Oncol. Res. Treat., 39. S. 87 - 88. BASEL: KARGER. ISSN 2296-5262

Schliemann, C., Pink, D., Floercken, A., Ahrens, M., Egerer, G., Goetze, K., Palmerini, E., Stacchiotti, S., Grignani, G., Rutkowski, P., Ullrich, R., Strapatsas, J., Hemmerle, T., Neri, D. and Kessler, T. (2021). A phase III study comparing the efficacy of the combination of doxorubicin and the tumor-targeting human antibody-cytokine fusion protein L19TNF to doxorubicin alone as first-line therapy in patients with advanced or metastatic soft tissue sarcoma. Ann. Oncol., 32. S. S1127 - 1. AMSTERDAM: ELSEVIER. ISSN 1569-8041

Suleiman, A. A., Schoettle, J., Jaehde, U., Ullrich, R. and Fuhr, U. (2016). High-pulsed doses of erlotinib for the treatment of non-small-cell lung cancer: A modeling analysis. Naunyn-Schmiedebergs Arch. Pharmacol., 389 (1). S. S70 - 2. NEW YORK: SPRINGER. ISSN 1432-1912

Volz, C., Zaplatina, A., Siobal, M., Chatterjee, S., Schoettle, J., Meder, L., Florin, A., Koker, M., Buettner, R., Miao, H., Wang, B., Hallek, M., Acker-Palmer, A. S., Heukamp, L. C., Thomas, R. K. and Ullrich, R. (2016). Anti angiogenic treatment induces tumor cell invasion and metastasis via EphA2 signaling in NSCLC. Oncol. Res. Treat., 39. S. 88 - 89. BASEL: KARGER. ISSN 2296-5262

This list was generated on Fri May 27 02:40:48 2022 CEST.